All
Research
Education
연구
교육
Business
솔루션
KR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Türkçe
JA - 日本語
PL - Polski
RU - Русский
HE - עִברִית
AR - العربية
로그인
Jiaqiang Mo has not added Biography.
If you are Jiaqiang Mo and would like to personalize this page please email our Author Liaison for assistance.
Upregulation of the long noncoding RNA FOXD2-AS1 predicts poor prognosis in esophageal squamous cell carcinoma.
Cancer biomarkers : section A of Disease markers Feb, 2018 | Pubmed ID: 29286915
A hepatocyte differentiation model reveals two subtypes of liver cancer with different oncofetal properties and therapeutic targets.
Proceedings of the National Academy of Sciences of the United States of America 03, 2020 | Pubmed ID: 32123069
Identification of prognostic claudins signature in hepatocellular carcinoma from a hepatocyte differentiation model.
Hepatology international Jul, 2020 | Pubmed ID: 32304089
Targeting tumor lineage plasticity in hepatocellular carcinoma using an anti-CLDN6 antibody-drug conjugate.
Science translational medicine 02, 2021 | Pubmed ID: 33536280
Laparoscopic anatomical SVIII resection middle hepatic fissure approach: Caudal or cranio side.
World journal of gastrointestinal surgery Dec, 2024 | Pubmed ID: 39734445
The second affiliated hospital of Guangzhou university of Chinese Medicine
Qing Ye1,
Shengfeng Zhou1,
Jie Cheng2,
Junming He1,
Jianxin Peng1,
Jiaqiang Mo1,
Zhangyuanzhu Liu1,
Jianyi Wang1,
Haorong Xie1,
Xuefang Chen1,
Jingfang Diao1
1, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine,
2, Guangzhou University of Chinese Medicine
개인 정보 보호
이용 약관
정책
연락처
사서에게 추천하기
JoVE 뉴스레터
JoVE Journal
연구 방법 컬렉션
JoVE Encyclopedia of Experiments
아카이브
JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Quiz
JoVE Playlist
저자
사서
액세스
JoVE 소개
JoVE Sitemap
Copyright © 2025 MyJoVE Corporation. 판권 소유
